As Novo Nordisk transitions from the leadership of longtime CEO Lars Fruergaard Jørgensen to newly appointed chief Maziar ...

Bagsværd, Denmark, 16 May 2025 – Novo Nordisk today announced changes to its executive leadership and Board of Directors. As per mutual agreement with the Novo Nordisk Board, Lars Fruergaard ...

Lars Fruergaard Jørgensen says: “Serving as Novo Nordisk’s CEO for the past eight years has been a privilege and an experience that I will always cherish.

Novo Nordisk has been through a significant growth journey and transformation led by Lars Fruergaard Jørgensen. During his eight-year tenure as CEO, Novo Nordisk’s sales, profits and share price have ...

Lars Fruergaard Jørgensen joined Novo Nordisk in 1991 and was appointed chief executive officer in January 2017. During his time at the helm, the company has grown tremendously, fortified its ...

Wegovy-maker Novo Nordisk said today its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

On behalf of the Board, I would like to thank Lars Fruergaard Jørgensen for his outstanding contributions to Novo Nordisk's success during his tenure as CEO. He is highly respected both inside and ...

Lars Fruergaard Jorgensen, incoming chief executive of Novo Nordisk, says the Danish drugmaker is “a very value-based company”, but when asked how he embodies the “Novo Nordisk Way ...

If Danes were given to superstition they would be waving every lucky charm going in the direction of Lars Fruergaard Jorgensen. More, they should be giving him daily thanks and checking on his ...

Lars Fruergaard Jorgensen And on Tresiba performance, we ended 2016 with market share of around 5% in the U.S. We have added 3.5% so far this year, partly fueled by the contract changes.